Earnings per share

6 Months Ended

Dec. 31, 2024

Text block [abstract]

Earnings per share

Note 18. Earnings per share


		Consolidated December 2024				Consolidated December 2023
		$				$
Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(10,453,811	)			(8,823,513	)


		Number				Number
Weighted average number of ordinary shares used in calculating basic earnings per share			425,157,427				239,779,384

Weighted average number of ordinary shares used in calculating diluted earnings per share			425,157,427				239,779,384


		Cents				Cents
Basic earnings per share			(2.459	)			(3.680	)
Diluted earnings per share			(2.459	)			(3.680	)